Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable MMR-deficient Solid Tumors × balstilimab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 5 Neoplasm Metastasis 2 Stomach Neoplasms 1 Sarcoma 1 Resectable MMR-deficient Solid Tumors 1 Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1 Rectal Neoplasms 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Cancer Metastatic 1 Advanced Renal Cell Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06279130 2026-03-05

NEOASIS

The Netherlands Cancer Institute

Phase 2/3 Recruiting

Other solid neoplasm

Resectable MMR-deficient Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡